GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Pre-Tax Income

Fulgent Genetics (MEX:FLGT) Pre-Tax Income : MXN-2,786 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Fulgent Genetics's pretax income for the three months ended in Jun. 2024 was MXN-205 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was MXN-2,786 Mil. Fulgent Genetics's pretax margin was -15.79%.

During the past 10 years, Fulgent Genetics's highest Pretax Margin was 69.17%. The lowest was -77.46%. And the median was -18.87%.


Fulgent Genetics Pre-Tax Income Historical Data

The historical data trend for Fulgent Genetics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Pre-Tax Income Chart

Fulgent Genetics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.71 5,802.18 13,894.13 3,587.75 -2,954.96

Fulgent Genetics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -252.02 119.49 -2,464.59 -235.22 -205.44

Competitive Comparison of Fulgent Genetics's Pre-Tax Income

For the Diagnostics & Research subindustry, Fulgent Genetics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fulgent Genetics's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's Pre-Tax Income falls into.



Fulgent Genetics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Fulgent Genetics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1278.076+-2040.882+0+363.996+0
=-2,955

Fulgent Genetics's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-346.36+0+0+140.918+0
=-205

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-2,786 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fulgent Genetics  (MEX:FLGT) Pre-Tax Income Explanation

Fulgent Genetics's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-205.442/1301.24
=-15.79%

During the past 10 years, Fulgent Genetics's highest Pretax Margin was 69.17%. The lowest was -77.46%. And the median was -18.87%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fulgent Genetics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Fulgent Genetics Business Description

Traded in Other Exchanges
Address
4978 Santa Anita Avenue, Temple City, CA, USA, 91780
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Fulgent Genetics Headlines

From GuruFocus